scholarly journals Respiratory health and quality of life in young exclusive, habitual smokers - a comparison of waterpipe smokers, cigarette smokers and non-smokers

2019 ◽  
Vol Volume 14 ◽  
pp. 1813-1824 ◽  
Author(s):  
F.I. Hawari ◽  
N.A. Obeidat ◽  
M. Abu Alhalawa ◽  
Z. Al-Busaidi ◽  
B. Amara ◽  
...  
2019 ◽  
Author(s):  
Elizabeth Yonko ◽  
Erin Carter ◽  
Robert Sandhaus ◽  
Cathleen Raggio

2014 ◽  
Vol 103 (8) ◽  
pp. 850-855 ◽  
Author(s):  
Katri Backman ◽  
Eija Piippo-Savolainen ◽  
Hertta Ollikainen ◽  
Heikki Koskela ◽  
Matti Korppi

2013 ◽  
Vol 36 (3) ◽  
pp. 460-466 ◽  
Author(s):  
Donee Alexander ◽  
Jacqueline Callihan Linnes ◽  
Susan Bolton ◽  
Timothy Larson

Breathe ◽  
2021 ◽  
Vol 17 (1) ◽  
pp. 210002
Author(s):  
Sonal Kansra ◽  
Rachel Calvert ◽  
Steve Jones

Children with respiratory diseases take treatments for the self-management of symptoms and to maintain disease control. Often, these treatments need to be taken in social environments like school. Respiratory treatments can foster a feeling of difference and stigmatisation, which negatively impact on the quality of life and adherence to treatment. Such perceptions can lead to a less than optimal disease control, a vicious cycle leading to further social exclusion and stigma. This aspect of “burden of treatment” is poorly recognised by clinicians. Recognition of how treatments and clinical practice can contribute to stigma, can help address this burden of care.Educational aimsTo understand the meaning of the term “stigma” within the context of respiratory health conditions and how medication or treatments can contribute to stigma in children and young people.To understand the potential impact of stigma on adherence, disease control and quality of life.To consider strategies to manage the stigma associated with health treatments across spheres of influence.


Thorax ◽  
2020 ◽  
Vol 75 (3) ◽  
pp. 279-288 ◽  
Author(s):  
Claire L Boswell-Ruys ◽  
Chaminda R H Lewis ◽  
Nirupama S Wijeysuriya ◽  
Rachel A McBain ◽  
Bonsan Bonne Lee ◽  
...  

BackgroundRespiratory complications remain a leading cause of morbidity and mortality in people with acute and chronic tetraplegia. Respiratory muscle weakness following spinal cord injury-induced tetraplegia impairs lung function and the ability to cough. In particular, inspiratory muscle strength has been identified as the best predictor of the likelihood of developing pneumonia in individuals with tetraplegia. We hypothesised that 6 weeks of progressive respiratory muscle training (RMT) increases respiratory muscle strength with improvements in lung function, quality of life and respiratory health.MethodsSixty-two adults with tetraplegia participated in a double-blind randomised controlled trial. Active or sham RMT was performed twice daily for 6 weeks. Inspiratory muscle strength, measured as maximal inspiratory pressure (PImax) was the primary outcome. Secondary outcomes included lung function, quality of life and respiratory health. Between-group comparisons were obtained with linear models adjusting for baseline values of the outcomes.ResultsAfter 6 weeks, there was a greater improvement in PImax in the active group than in the sham group (mean difference 11.5 cmH2O (95% CI 5.6 to 17.4), p<0.001) and respiratory symptoms were reduced (St George Respiratory Questionnaire mean difference 10.3 points (0.01–20.65), p=0.046). Significant improvements were observed in quality of life (EuroQol-Five Dimensional Visual Analogue Scale 14.9 points (1.9–27.9), p=0.023) and perceived breathlessness (Borg score 0.64 (0.11–1.17), p=0.021). There were no significant improvements in other measures of respiratory function (p=0.126–0.979).ConclusionsProgressive RMT increases inspiratory muscle strength in people with tetraplegia, by a magnitude which is likely to be clinically significant. Measurement of baseline PImax and provision of RMT to at-risk individuals may reduce respiratory complications after tetraplegia.Trial registration numberAustralian New Zealand Clinical Trials Registry (ACTRN 12612000929808).


2016 ◽  
Vol 36 (5) ◽  
pp. 472-479 ◽  
Author(s):  
Branwen A. Bryan ◽  
Alex Battersby ◽  
Benjamin Martin James Shillitoe ◽  
Dawn Barge ◽  
Helen Bourne ◽  
...  

2019 ◽  
Vol 6 (2) ◽  
pp. 341
Author(s):  
Javed Akhter

Background: Yoga is science of simple living that enlightens all aspects of life physical, mental, psychic and spiritual. Yoga helps in balancing and harmonizing body mind and emotions. Yoga improves pulmonary ventilation and gas exchange. Thus, it improves respiratory health and general wellbeing of individual. Aim was to assess role of yoga in improving the quality of life of hypothyroidism patients before and after 6 months of yoga.Methods: Sixty adult patients of hypothyroidism participated in this prospective study and were divided into two groups. Quality of life of all the patients was assessed by WHO QOL BREF document in form of. The data obtained was analyzed using SPSS software (version 16.0). Four domain scores were assessed. Unpaired t test and paired t test was to compare normal controls with hypothyroid patients.Results: There was a significant improvement of 17.79% in the physical aspect of quality of life of patients in the yoga group at the end of six months as compared to the patients in the control group. Significant improvement of 18.38% was also observed in the psychological aspect of quality of life of patients in the yoga group at the end of six months as compared to control group.Conclusions: There is a profound improvement in physical and psychological domains of quality of life of hypothyroid patients. However, further studies over longer period of time may be helpful to evaluate the effect of yoga in these aspects of life.


Sign in / Sign up

Export Citation Format

Share Document